Figure 7.
Biological functions and mechanistic studies of the prognostic biomarker. (a) Expression level of CNFN in tumor and normal tissues detected using RT-qPCR; (b) Expression level of CNFN in tumor tissues between lymph node metastasis and non-lymph node metastasis detected using RT-qPCR; (c–e) Cell proliferation capacity was validated using colony formation and CCK-8 assays; f: Cell migration ability was evaluated using wound healing assay; (g) Transwell migration assay was used to assess the effects of CNFN on cell migration ability; (h) Transwell invasion assay was utilized to evaluate the effects of CNFN on cell invasion ability; (i) Western blotting was used to detect changes in the expression levels of EMT-associated markers after silencing of CNFN.